首页> 外文期刊>European Journal of Nuclear Medicine and Molecular Imaging >Potential impact of (68)Ga-DOTATOC PET/CT on stereotactic radiotherapy planning of meningiomas.
【24h】

Potential impact of (68)Ga-DOTATOC PET/CT on stereotactic radiotherapy planning of meningiomas.

机译:(68)Ga-DOTATOC PET / CT对脑膜瘤立体定向放射治疗计划的潜在影响。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: Since meningiomas show a high expression of somatostatin receptor subtype 2, PET with (68)Ga-DOTATOC was proposed as an additional imaging modality beside CT and MRI for planning radiotherapy. We investigated the input of (68)Ga-DOTATOC-PET/CT on the definition of the "gross tumour volume" (GTV) in meningiomas, in order to assess the potential value of this method. METHODS: Prior to radiotherapy, 42 patients with meningiomas (26 f, 16 m, mean age 55) underwent MRI and (68)Ga-DOTATOC-PET/CT examinations. History: operated n = 24, radiotherapy n = 1, operation and radiotherapy n = 8, no treatment n = 9. PET/CT and MRI data were co-registered using a BrainLAB workstation. For comparison, the GTV was defined first under consideration of CT and MRI data, then using PET data. RESULTS: 3/42 patients were excluded from the analysis (two with negative PET results, one with an extensive tumour, not precisely delineable by MRI or PET/CT). The average GTV(CT/MRI) was 22(+/-19)cm(3); GTV(PET) was 23(+/-20)cm(3). Additional GTV, obtained as a result of PET was 9(+/-10)cm(3) and was observed in patients with osseous infiltration. In some pre-treated patients there were intratumoural areas (as identified in CT/MRI) without SR-expression (7(+/-11)cm(3)). Common GTV as obtained by both CT/MRI and PET was 15(+/-14)cm(3). The mean bi-directional difference between the GTV(CT/MRI) and GTV(PET) accounted to 16(+/-15)cm(3) (93%, p < 0.001). In a subgroup of seven patients with multiple meningiomas, PET showed a total of 19 lesions; nine of them were not recognizable by CT or MRI. CONCLUSION: (68)Ga-DOTATOC-PET enables delineation of SR-positive meningiomas and delivers additional information to both CT and MRI regarding the planning of stereotactic radiotherapy. The acquisition on a PET/CT scanner helps to estimate the relation of PET findings to anatomical structures and is especially useful for detection of osseous infiltration. (68)Ga-DOTATOC-PET also allows detection of additional lesions in patients with multiple meningiomas.
机译:目的:由于脑膜瘤显示出生长抑素受体亚型2的高表达,建议与(68)Ga-DOTATOC一起使用的PET作为CT和MRI之外的另一种成像方式,以计划放射治疗。为了评估该方法的潜在价值,我们调查了(68)Ga-DOTATOC-PET / CT对脑膜瘤“大肿瘤体积”(GTV)定义的输入。方法:在放疗前,对42例脑膜瘤患者(26 f,16 m,平均年龄55岁)进行了MRI和(68)Ga-DOTATOC-PET / CT检查。历史:手术n = 24,放射治疗n = 1,手术和放射治疗n = 8,未接受治疗n =9。使用BrainLAB工作站对PET / CT和MRI数据进行了共同注册。为了进行比较,首先考虑CT和MRI数据,然后使用PET数据定义GTV。结果:3/42例患者被排除在分析之外(两名PET结果阴性,一名肿瘤广泛,无法通过MRI或PET / CT准确描述)。平均GTV(CT / MRI)为22(+/- 19)cm(3); GTV(PET)为23(+/- 20)cm(3)。通过PET获得的额外GTV为9(+/- 10)cm(3),在骨浸润患者中观察到。在一些经过预处理的患者中,肿瘤内区域(如CT / MRI所示)没有SR表达(7(+/- 11)cm(3))。通过CT / MRI和PET获得的普通GTV为15(+/- 14)cm(3)。 GTV(CT / MRI)和GTV(PET)之间的平均双向差异为16(+/- 15)cm(3)(93%,p <0.001)。在7名多发性脑膜瘤患者的亚组中,PET总共显示19个病灶。其中有9个无法通过CT或MRI识别。结论:(68)Ga-DOTATOC-PET能够描述SR阳性脑膜瘤,并向CT和MRI提供有关立体定向放疗计划的更多信息。 PET / CT扫描仪上的采集有助于估计PET表现与解剖结构之间的关系,对于检测骨浸润尤其有用。 (68)Ga-DOTATOC-PET还可以检测出多发性脑膜瘤患者的其他病变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号